Koh‐ichi Nakashiro

4.0k total citations
127 papers, 3.3k citations indexed

About

Koh‐ichi Nakashiro is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Koh‐ichi Nakashiro has authored 127 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 52 papers in Oncology and 35 papers in Cancer Research. Recurrent topics in Koh‐ichi Nakashiro's work include Head and Neck Cancer Studies (26 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Cancer-related Molecular Pathways (15 papers). Koh‐ichi Nakashiro is often cited by papers focused on Head and Neck Cancer Studies (26 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Cancer-related Molecular Pathways (15 papers). Koh‐ichi Nakashiro collaborates with scholars based in Japan, United States and Italy. Koh‐ichi Nakashiro's co-authors include Hiroyuki Hamakawa, Satoru Shintani, Daisuke Uchida, Hitoshi Kawamata, Mariko Mihara, Chunnan Li, Hideo Yoshida, Ryoichi Oyasu, Mitsunobu Sato and Nagaaki Terakado and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Koh‐ichi Nakashiro

119 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koh‐ichi Nakashiro Japan 34 1.7k 1.4k 802 494 492 127 3.3k
Hiroyuki Hamakawa Japan 32 1.3k 0.8× 1.4k 1.0× 542 0.7× 439 0.9× 391 0.8× 145 3.0k
Edgar Selzer Austria 35 1.7k 1.0× 951 0.7× 525 0.7× 360 0.7× 604 1.2× 106 3.7k
Jennifer R. Grandis United States 29 2.2k 1.3× 2.8k 2.0× 813 1.0× 788 1.6× 615 1.3× 42 4.3k
Kenneth K. Iwata United States 27 1.9k 1.1× 1.8k 1.2× 520 0.6× 976 2.0× 169 0.3× 50 3.4k
Ning T. Yeh United States 12 1.1k 0.7× 855 0.6× 684 0.9× 188 0.4× 360 0.7× 12 2.0k
Ryo Miyahara Japan 35 1.1k 0.7× 1.5k 1.0× 591 0.7× 1.4k 2.8× 275 0.6× 101 3.3k
R.R. Weichselbaum United States 28 1.8k 1.0× 1.2k 0.8× 659 0.8× 625 1.3× 465 0.9× 64 3.5k
M Imamura Japan 27 1.5k 0.9× 1.2k 0.9× 720 0.9× 552 1.1× 176 0.4× 79 2.9k
Sichuan Xi United States 32 2.0k 1.2× 1.4k 1.0× 754 0.9× 568 1.1× 371 0.8× 55 3.2k
Shiu‐Feng Huang Taiwan 29 1.4k 0.8× 1.2k 0.9× 596 0.7× 944 1.9× 275 0.6× 78 2.9k

Countries citing papers authored by Koh‐ichi Nakashiro

Since Specialization
Citations

This map shows the geographic impact of Koh‐ichi Nakashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh‐ichi Nakashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh‐ichi Nakashiro more than expected).

Fields of papers citing papers by Koh‐ichi Nakashiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh‐ichi Nakashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh‐ichi Nakashiro. The network helps show where Koh‐ichi Nakashiro may publish in the future.

Co-authorship network of co-authors of Koh‐ichi Nakashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Koh‐ichi Nakashiro. A scholar is included among the top collaborators of Koh‐ichi Nakashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh‐ichi Nakashiro. Koh‐ichi Nakashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nakashiro, Koh‐ichi, et al.. (2024). Clinical significance of gene alterations in oral squamous cell carcinoma. Japanese Journal of Oral & Maxillofacial Surgery. 70(3). 110–117. 1 indexed citations
3.
Nakashiro, Koh‐ichi, et al.. (2024). Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma. Cancer Medicine. 13(18). e70263–e70263. 3 indexed citations
4.
Nakashiro, Koh‐ichi, et al.. (2024). Possible Role of miR-375-3p in Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma. Cancers. 16(8). 1492–1492. 2 indexed citations
5.
Goda, Hiroyuki, Tomoko Adachi, Koh‐ichi Nakashiro, Nobuyuki Kuribayashi, & Daisuke Uchida. (2024). Abstract LB329: Interleukin6 as a Potential Prognostic Marker and Therapeutic Target in Oral Squamous Cell Carcinoma. Cancer Research. 84(7_Supplement). LB329–LB329. 1 indexed citations
6.
Nakashiro, Koh‐ichi, et al.. (2023). MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma. Cancers. 15(16). 4138–4138. 2 indexed citations
7.
Otsuru, Mitsunobu, Souichi Yanamoto, Shin‐ichi Yamada, et al.. (2023). Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan. International Journal of Environmental Research and Public Health. 20(5). 4545–4545. 2 indexed citations
8.
Komiyama, Yuske, et al.. (2020). Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro. International Journal of Molecular Sciences. 21(17). 6292–6292. 13 indexed citations
9.
Nakashiro, Koh‐ichi, et al.. (2020). MicroRNA‐361‐3p is a potent therapeutic target for oral squamous cell carcinoma. Cancer Science. 111(5). 1645–1651. 22 indexed citations
10.
Goda, Hiroyuki, et al.. (2019). Locally advanced mammary analogue secretory carcinoma of the parotid gland. International Journal of Oral and Maxillofacial Surgery. 48(7). 865–868. 8 indexed citations
11.
Kitamura, Naoya, Tetsuya Yamamoto, Koh‐ichi Nakashiro, et al.. (2017). Palonosetron Prevents Highly Emetogenic Chemotherapyinduced Nausea and Vomiting in Oral Cancer Patients. Anticancer Research. 37(12). 6977–6981. 1 indexed citations
12.
Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2013). Prognostic Impact of Expression of Bcl-2 and Bax Genes in Circulating Immune Cells Derived from Patients with Head and Neck Carcinoma. Neoplasia. 15(3). 305–IN35. 18 indexed citations
13.
Sumida, Tomoki, et al.. (2009). Methotrexate-induced malignant lymphoma in the maxilla of a patient with rheumatoid arthritis. Japanese Journal of Oral & Maxillofacial Surgery. 55(9). 463–466. 5 indexed citations
14.
Isokane, Mayumi, Miki Hieda, Satoshi Hirakawa, et al.. (2008). Plasma-membrane-anchored growth factor pro-amphiregulin binds A-type lamin and regulates global transcription. Journal of Cell Science. 121(21). 3608–3618. 34 indexed citations
15.
Kłosek, Sebastian, Koh‐ichi Nakashiro, Shingo Hara, et al.. (2004). Constitutive activation of Stat3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma. Oncology Reports. 12(2). 293–6. 21 indexed citations
16.
Shintani, Satoru, Mariko Mihara, Chunnan Li, et al.. (2003). Up‐regulation of DNA‐dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Science. 94(10). 894–900. 109 indexed citations
17.
Nakashiro, Koh‐ichi, Hitoshi Kawamata, Daisuke Uchida, et al.. (2002). Expression of peroxisome proliferator-activated receptor γ and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines. International Journal of Oncology. 20(3). 599–605. 10 indexed citations
18.
Mihara, Mariko, Satoru Shintani, Koh‐ichi Nakashiro, & Hiroyuki Hamakawa. (2002). Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells. Oral Oncology. 39(1). 49–55. 24 indexed citations
19.
Hoque, Mohammad Obaidul, Hiroshi Kawamata, Koh‐ichi Nakashiro, et al.. (2001). Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. International Journal of Oncology. 19(5). 953–8. 10 indexed citations
20.
Kawamata, Hitoshi, Koh‐ichi Nakashiro, Daisuke Uchida, et al.. (1997). Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. International Journal of Cancer. 70(1). 120–127. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026